Shares of Auris Medical Holding AG (NASDAQ:EARS) gapped up before the market opened on Wednesday . The stock had previously closed at $3.63, but opened at $3.84. Auris Medical Holding AG shares last traded at $5.23, with a volume of 1,962,838 shares.

A number of analysts have commented on EARS shares. Zacks Investment Research lowered Auris Medical Holding AG from a “buy” rating to a “hold” rating in a report on Tuesday. Jefferies Group reissued a “buy” rating on shares of Auris Medical Holding AG in a report on Friday, June 10th. Finally, Leerink Swann reissued a “buy” rating on shares of Auris Medical Holding AG in a report on Thursday, May 12th.

The firm’s market capitalization is $183.66 million. The stock’s 50-day moving average is $4.09 and its 200-day moving average is $3.96.

Auris Medical Holding AG is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. Its advanced product candidate, AM-101, is in Phase III clinical development for acute inner ear tinnitus under a special protocol assessment (SPA) from the United States Food and Drug Administration.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.